PUBLISHER: The Business Research Company | PRODUCT CODE: 1945535
PUBLISHER: The Business Research Company | PRODUCT CODE: 1945535
A medical device contract research organization (CRO) is a specialized service provider that offers outsourced research and development support to medical device manufacturers. These organizations assist companies in navigating the complex process of developing a medical device from concept to market, ensuring regulatory compliance, and achieving successful clinical outcomes. CROs play a critical role in reducing the time, cost, and risks associated with medical device development.
Key services provided by medical device CROs include project management or clinical supply management, regulatory or medical affairs, medical writing, clinical monitoring, quality management or assurance, biostatistics, investigator payments, laboratory services, patient and site recruitment, and more. Project management or clinical supply management focuses on overseeing the planning, execution, and coordination of clinical trials, ensuring that necessary supplies, including medical devices and drugs, are available at trial sites. The types of devices covered include medtech devices, diagnostic devices, handheld devices, and others. The phases include preclinical and clinical, with applications spanning cardiology, diagnostic imaging, orthopedics, in vitro diagnostics (IVD), ophthalmology, general and plastic surgery, and drug delivery.
Tariffs are influencing the medical device CRO market by increasing costs of imported laboratory equipment, clinical trial supplies, diagnostic tools, and data management infrastructure. CRO operations supporting multinational trials in North America and Europe are most affected due to cross-border sourcing dependencies, while Asia-Pacific faces cost pressures on trial execution services. These tariffs are increasing overall study budgets and operational expenses. At the same time, they are encouraging regional trial localization, local vendor partnerships, and investment in domestic clinical research capabilities.
The medical device contract research organization (cro) market research report is one of a series of new reports from The Business Research Company that provides medical device contract research organization (cro) market statistics, including medical device contract research organization (cro) industry global market size, regional shares, competitors with a medical device contract research organization (cro) market share, detailed medical device contract research organization (cro) market segments, market trends and opportunities, and any further data you may need to thrive in the medical device contract research organization (cro) industry. This medical device contract research organization (cro) market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.
The medical device contract research organization (cro) market size has grown strongly in recent years. It will grow from $10.64 billion in 2025 to $11.39 billion in 2026 at a compound annual growth rate (CAGR) of 7.0%. The growth in the historic period can be attributed to increasing complexity of medical device regulations, growth in medical device innovation pipelines, rising clinical trial costs, limited in-house regulatory expertise, expansion of global clinical studies.
The medical device contract research organization (cro) market size is expected to see strong growth in the next few years. It will grow to $14.75 billion in 2030 at a compound annual growth rate (CAGR) of 6.7%. The growth in the forecast period can be attributed to increasing demand for accelerated device approvals, rising adoption of decentralized clinical trials, growing use of real-world evidence, expansion of post-market surveillance requirements, increasing integration of digital health technologies. Major trends in the forecast period include increasing outsourcing of clinical trial management, rising demand for regulatory compliance expertise, growing adoption of data-driven clinical research, expansion of remote and hybrid clinical monitoring models, enhanced focus on risk-based quality management.
The rise in clinical trials is anticipated to boost the growth of the medical device contract research organization (CRO) market. Clinical trials involve research studies with human participants aimed at assessing the safety and efficacy of new medical treatments, interventions, or diagnostic procedures. The growing number of clinical trials is driven by increased demand for innovative medical devices and regulatory requirements for thorough testing. Medical device contract research organizations (CROs) offer specialized expertise and resources to manage, conduct, and oversee these trials, ensuring compliance and efficiency. For example, in August 2024, the National Library of Medicine reported an increase in registered clinical trials from 477,227 in 2023 to 506,371 across 50 states and 221 countries. Additionally, 52,731 medical device studies were registered globally. This surge in clinical trials is expected to propel the medical device CRO market.
Leading companies in the medical device CRO market are focusing on integrating traditional services with advanced technologies and recruitment strategies, such as hybrid and virtual trial models, to improve trial efficiency, speed up participant enrollment, and streamline regulatory compliance. Virtual and hybrid site capabilities are designed to meet diverse study requirements and participant needs, particularly in response to the growing demand for decentralized trials. For instance, in June 2024, Lindus Health, a UK-based clinical trials company, introduced All-in-One Medical Device CRO, a comprehensive solution tailored for medical device trials. This offering combines traditional CRO services with advanced features such as Citrus eClinical technology. It integrates all essential trial tools into a single platform, including clinical trial management systems (CTMS), electronic data capture (EDC), and eConsent. The platform enhances recruitment with access to over 30 million electronic health records (EHRs) and strategic digital marketing, ensuring efficient and timely enrollment. Lindus Health also provides robust site services, managing trials across single-site, multi-site, and virtual/hybrid models through strong relationships with principal investigators and research staff.
In October 2023, Avania, a US-based clinical research organization that specializes in medical technology development, acquired HULL ASSOCIATES LLC and Ironstone Product Development (IPD) for an undisclosed amount. This acquisition is intended to enhance Avania's global capabilities in regulatory affairs, clinical trial management, and product development services. HULL ASSOCIATES LLC is a US-based consultancy that specializes in regulatory strategies, while Ironstone Product Development (IPD) is a Canada-based company focused on medical device development and commercialization strategies.
Major companies operating in the medical device contract research organization (cro) market are Thermo Fisher Scientific Inc., IQVIA Inc., Laboratory Corporation of America Holdings, ICON plc, Eurofins Scientific SE, WuXi AppTec, Syneos Health, Charles River Laboratories, PAREXEL International, Medpace Holdings Inc., Hangzhou Tigermed Consulting Co. Ltd., Caidya, QPS Holdings LLC, Avania B.V., Veristat, Cromsource S.R.L., Osmunda Medical Technology Service Group, MedTrials Inc., Boston Biomedical Associates, Hangzhou CIRS Technology Group Co. Ltd., Clinlogix, Shanghai Haofeng Medical Technology Co. Ltd., Promedica International, Medidee Services
Asia-Pacific was the largest region in the medical device contract research organization (CRO) market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the medical device contract research organization (cro) market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.
The countries covered in the medical device contract research organization (cro) market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain
The medical device contract research organization (CRO) market includes revenues earned by companies providing outsourced research and development services, such as clinical trials, regulatory affairs, and product development support, to medical device manufacturers. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.
The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).
The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.
Medical Device Contract Research Organization (CRO) Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.
This report focuses medical device contract research organization (cro) market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.
Where is the largest and fastest growing market for medical device contract research organization (cro) ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The medical device contract research organization (cro) market global report from the Business Research Company answers all these questions and many more.
The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.
Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.